This kinase is most known for its role in many invasive and metastatic cancers, such as breast cancer, lung cancer, neck cancer, ovarian cancer, and prostate cancer, where high FAK levels are associated with poor prognosis. The gene discussed is PTK2; the disease is metastatic malignant neoplasm.